Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$459K Sell
21,025
-3,016
-13% -$69.9K 0.01% 990
2025
Q4
$566K Sell
24,041
-2,766
-10% -$66.7K 0.01% 867
2025
Q3
$759K Buy
26,807
+10,582
+65% +$281K 0.01% 726
2025
Q2
$357K Buy
16,225
+4,803
+42% +$105K 0.01% 1075
2025
Q1
$266K Sell
11,422
-3,089
-21% -$79K ﹤0.01% 1166
2024
Q4
$415K Buy
14,511
+3,154
+28% +$94.4K 0.01% 999
2024
Q3
$335K Buy
11,357
+356
+3% +$11.1K ﹤0.01% 1141
2024
Q2
$370K Buy
+11,001
New +$380K 0.01% 980

Other funds holding GNTX

Choreo LLC's GNTX Position: Q1 2026 in Review

Choreo LLC reduced its Gentex (GNTX) stake by 13% in Q1 2026, selling an estimated $69.9K and leaving 21,025 shares worth $459K. The position accounts for 0.01% of the portfolio, ranked #990.

Choreo LLC first reported a position in GNTX in Q2 2024 and has held it in 8 quarters since. The position peaked at $759K in Q3 2025. 501 funds tracked by Wall St. Rank hold GNTX as of Q1 2026.

  • Choreo LLC held 21,025 shares of Gentex worth $459K as of Q1 2026.
  • Choreo LLC sold 3,016 Gentex shares in Q1 2026, an estimated $69.9K.
  • Gentex made up 0.01% of Choreo LLC's portfolio in Q1 2026, its #990 holding.
  • Choreo LLC first reported a position in Gentex in Q2 2024 and has held it in 8 quarters since.
  • Choreo LLC's Gentex position peaked at $759K in Q3 2025.
  • 501 funds tracked by Wall St. Rank held Gentex as of Q1 2026.

Based on Choreo LLC's 13F filing for Q1 2026, filed 13 May 2026.